Glycemic variability correlates with medial temporal lobe atrophy and decreased cognitive performance in patients with memory deficits.
MMSE
MTA
MoCA
blood glucose variability
glycemic variability
medial temporal atrophy
Journal
Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
02
2023
accepted:
28
06
2023
medline:
3
8
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
In the past, researchers have observed a significant link between glycemia and dementia. Medial temporal atrophy (MTA) is regarded as a common marker of dementia. The correlation between glycemic variability and MTA is unclear, and it has not been determined whether glycemic variability can be utilized as a biomarker of MTA and cognitive performance. The patients in a memory clinic who underwent brain MRI scans and cognitive assessments within the first week of their hospital visit, were enrolled. All participants underwent three fasting blood glucose and one HBA1c assessments on three self-selected days within 1 week of their first visit. The variability independent of the mean (VIM) was employed. Validated visual scales were used to rate the MTA results. The mini-mental state examination (MMSE) and Montreal Cognitive Assessment (MoCA) scales were employed to assess the cognitive functions of the participants. Spearman's correlation and regression models were used to examine the relationship between the MMSE and MoCA scales, and also determine the link between the MRI characteristics and cognitive status, where vascular risk factors, educational status, age, gender, and mean glucose parameters served as covariates. Four hundred sixty-one subjects completed the MMSE scale, while 447 participants completed the MoCA scale. Data analysis revealed that 47.72% of the participants were men (220/461), and the median age of the patients was 69.87 ± 5.37 years. The findings of Spearman's correlation analysis exhibited a strong negative relationship between the VIM and MMSE score ( The variability in the blood glucose levels, which was presented as VIM, was related to the reduced cognitive function, which was reflected by MMSE and MoCA scales. The relationship between the VIM and the MTA score was non-linear. The VIM was positively related to the MTA score when the VIM was less than 2.42.
Sections du résumé
Background
UNASSIGNED
In the past, researchers have observed a significant link between glycemia and dementia. Medial temporal atrophy (MTA) is regarded as a common marker of dementia. The correlation between glycemic variability and MTA is unclear, and it has not been determined whether glycemic variability can be utilized as a biomarker of MTA and cognitive performance.
Methods
UNASSIGNED
The patients in a memory clinic who underwent brain MRI scans and cognitive assessments within the first week of their hospital visit, were enrolled. All participants underwent three fasting blood glucose and one HBA1c assessments on three self-selected days within 1 week of their first visit. The variability independent of the mean (VIM) was employed. Validated visual scales were used to rate the MTA results. The mini-mental state examination (MMSE) and Montreal Cognitive Assessment (MoCA) scales were employed to assess the cognitive functions of the participants. Spearman's correlation and regression models were used to examine the relationship between the MMSE and MoCA scales, and also determine the link between the MRI characteristics and cognitive status, where vascular risk factors, educational status, age, gender, and mean glucose parameters served as covariates.
Results
UNASSIGNED
Four hundred sixty-one subjects completed the MMSE scale, while 447 participants completed the MoCA scale. Data analysis revealed that 47.72% of the participants were men (220/461), and the median age of the patients was 69.87 ± 5.37 years. The findings of Spearman's correlation analysis exhibited a strong negative relationship between the VIM and MMSE score (
Conclusion
UNASSIGNED
The variability in the blood glucose levels, which was presented as VIM, was related to the reduced cognitive function, which was reflected by MMSE and MoCA scales. The relationship between the VIM and the MTA score was non-linear. The VIM was positively related to the MTA score when the VIM was less than 2.42.
Identifiants
pubmed: 37533764
doi: 10.3389/fnagi.2023.1156908
pmc: PMC10390778
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1156908Informations de copyright
Copyright © 2023 Zhang, Wang, Liu, Liu, Zhu and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Diabetes Complications. 2018 Jul;32(7):682-687
pubmed: 29793824
Adv Nutr. 2014 Mar 01;5(2):119-30
pubmed: 24618754
Neurology. 1993 Feb;43(2):250-60
pubmed: 8094895
PLoS One. 2015 Jul 01;10(7):e0132118
pubmed: 26132234
Clin Geriatr Med. 2020 Aug;36(3):407-417
pubmed: 32586471
Neurochem Int. 2017 Sep;108:296-302
pubmed: 28551028
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Lancet Diabetes Endocrinol. 2015 Jan;3(1):75-89
pubmed: 25163604
Psychiatr Pol. 1994 Mar-Apr;28(2):255-68
pubmed: 8208869
Aging (Albany NY). 2020 Mar 17;12(6):4945-4952
pubmed: 32181754
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Alzheimers Dement. 2020 Jun;16(6):843-852
pubmed: 32323446
J Diabetes Investig. 2020 Jul;11(4):971-979
pubmed: 31999889
J Diabetes Res. 2020 Nov 24;2020:6666403
pubmed: 33299890
J Alzheimers Dis. 2019;67(4):1255-1265
pubmed: 30689569
Psychiatry Res. 2010 Sep 30;183(3):237-43
pubmed: 20705437
Health Psychol. 2016 Feb;35(2):199-202
pubmed: 26523354
Front Endocrinol (Lausanne). 2022 May 09;13:873301
pubmed: 35615716
Neurobiol Aging. 2012 Jul;33(7):1400-10
pubmed: 21450369
Res Gerontol Nurs. 2022 Jul-Aug;15(4):203-212
pubmed: 35708961
Diabetes Care. 2018 Mar;41(3):446-452
pubmed: 29255060
Ageing Res Rev. 2019 Nov;55:100944
pubmed: 31430566
Free Radic Biol Med. 2022 Nov 20;193(Pt 1):134-157
pubmed: 36206930
Neurology. 2018 Jul 31;91(5):e427-e435
pubmed: 29997193
Brain Commun. 2022 Mar 07;4(2):fcac052
pubmed: 35350552
Behav Brain Res. 2011 Sep 12;222(1):81-8
pubmed: 21420439
Scand J Prim Health Care. 2020 Sep;38(3):281-290
pubmed: 32777967
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1038-40
pubmed: 22566596
Diabetes. 2008 May;57(5):1349-54
pubmed: 18299315
J Diabetes Res. 2020 Apr 23;2020:4591938
pubmed: 32377520
J Alzheimers Dis. 2019;72(1):191-197
pubmed: 31561370
Lancet Neurol. 2008 Feb;7(2):184-90
pubmed: 18207116
Clin Soc Work J. 2020;48(2):196-210
pubmed: 32435074
Psychiatr Pol. 1994 Sep-Oct;28(5):509-21
pubmed: 7527563
Neurology. 2012 Sep 4;79(10):1019-26
pubmed: 22946113
PLoS One. 2013 Sep 04;8(9):e73697
pubmed: 24023897
J Alzheimers Dis. 2018;62(2):833-840
pubmed: 29480176
J Alzheimers Dis. 2022;89(4):1293-1302
pubmed: 36031896
J Alzheimers Dis. 2020;77(4):1431-1442
pubmed: 32925053
Diabetes Care. 2018 Dec;41(12):2610-2616
pubmed: 30254081
Front Aging Neurosci. 2022 Nov 17;14:1065117
pubmed: 36466611
Diabetologia. 2020 Jan;63(1):85-94
pubmed: 31485707
J Alzheimers Dis. 2014;42(4):1337-46
pubmed: 25024335
Alzheimers Dement. 2017 Mar;13(3):296-311
pubmed: 27825022
J Diabetes Complications. 2014 Jan-Feb;28(1):85-90
pubmed: 23352495
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
Nat Rev Neurol. 2018 Mar;14(3):168-181
pubmed: 29377010
Diabetes Metab. 2008 Dec;34(6 Pt 1):612-6
pubmed: 18824382
Alzheimers Dement. 2022 Nov;18(11):2373-2374
pubmed: 35901055
Alzheimers Dement. 2010 Nov;6(6):440-7
pubmed: 21044774
BMC Med. 2014 Sep 26;12:165
pubmed: 25255837
Nutrients. 2020 Dec 21;12(12):
pubmed: 33371247
Front Psychiatry. 2020 May 20;11:380
pubmed: 32508684
J Diabetes. 2022 Mar;14(3):205-215
pubmed: 35170854